Email reaches people at [email protected]
PeptideStack does not sell, prescribe, compound, or manufacture peptides
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." In addition, the regulator says BPC-157 is not approved for use in any NHPs in any form, including oral and injectable, but it can still be compounded for topical use or oral administration as an NHP
GLP-1 medications slow gastric emptying and alter gut motility, potentially affecting probiotic colonization and efficacy
It's like trying to find a hidden treasure, but instead of gold, you're looking for information about your health benefits